Archive: 20/03/2015

Serious risks from common IV devices mean doctors should choose carefully, experts say

Every day, patients around the country get IV devices placed in their arms, to make it easier to receive medicines or have blood drawn over the course of days or weeks. But these PICC lines, as they're called, also raise ...

Mar 20, 2015

0

64

Breastfeeding may offset leukemia risk

Breastfeeding could help reduce the risk of acute lymphoblastic leukemia in children, according to a WA-led study.

Mar 20, 2015

0

876

Emails: UN health agency resisted declaring Ebola emergency

In a delay that some say may have cost lives, the World Health Organization resisted calling the Ebola outbreak in West Africa a public health emergency until last summer, two months after staff raised the possibility and ...

Mar 20, 2015

0

5

Review of global guidelines for sepsis needed

Experts are calling for a global review of guidelines used to diagnose sepsis, after a study found one in eight patients with infections severe enough to need admission to an Intensive Care Unit in Australia and New Zealand, ...

Mar 20, 2015

Sipuleucel-T in prostate cancer: Indication of added benefit

Sipuleucel-T (trade name Provenge) has been approved since September 2014 for men with metastatic prostate cancer who have few or no symptoms and do not yet require chemotherapy. In the dossier assessment conducted by the ...

Mar 20, 2015

Autistic and non-autistic brain differences isolated for first time

The functional differences between autistic and non-autistic brains have been isolated for the first time, following the development of a new methodology for analysing MRI scans.

Mar 20, 2015

5

248

Novel therapy to treat patients with hereditary breast cancer and ovarian cancer

European scientists recently discovered a novel therapy to treat a subgroup of patients with hereditary breast/ovarian cancer. Both the EU and the US have approved an accelerated procedure to market this promising new treatment ...

Mar 20, 2015